structure human p2y12 receptor complex antithrombotic drug 
p2y receptors p2yrs family purinergic g-protein-coupled receptors gpcrs activated extracellular nucleotides total eight distinct functional p2yrs expressed human subdivided p2y1-like receptors p2y12-like receptors1 ligands generally charged molecules relatively low bioavailability stability vivo2 limits understanding receptor family p2y12r regulates platelet activation thrombus formation34 several antithrombotic drugs targeting p2y12r-including prodrugs clopidogrel plavix prasugrel effient metabolized bind covalently nucleoside analogue ticagrelor brilinta acts directly receptor-have approved prevention stroke myocardial infarction however limitations drugs example long half-life clopidogrel action characteristic adverse effect profile ticagrelor suggest unfulfilled medical need developing new generation p2y12r inhibitors78 report angstrom resolution crystal structure human p2y12r complex non-nucleotide reversible antagonist azd1283 structure reveals distinct straight conformation helix v sets p2y12r apart known class gpcr structures azd1283 bound highly conserved disulphide bridge gpcrs helix iii extracellular loop observed appears dynamic along details azd1283-binding site analysis extracellular interface reveals adjacent ligand-binding region suggests pockets required dinucleotide binding structure provides essential insights development improved p2y12r ligands allosteric modulators drug candidates 
